SCHEMBL8857002

SCHEMBL8857002

COc1ccc2c(=O)c(=NNc3ccc(N(C)S(C)(=O)=O)cc3)c(=O)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPT P10636 5/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TP53 P04637 2/20 0.41
STAT3 P40763 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 2/20 0.41
USP2 O75604 1/20 0.40
KDM4E B2RXH2 3/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PGR P06401 1/20 0.38
ATM Q13315 1/20 0.38
RAD52 P43351 1/20 0.38
GAA P10253 2/20 0.37
CYP2C9 P11712 1/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856796 0.84 SENP6 (0.48) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856799 0.84 SENP6 (0.48) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856994 0.83 MAPT (0.59) LMNAALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL8856730 0.80 LMNA (0.46) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856666 0.73 SENP6 (0.61) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856529 0.71 SMN1; SMN2 (0.44) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856505 0.71 SMN1; SMN2 (0.44) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL6321497 0.71 PGR (0.54) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL8856707 0.67 SENP6 (0.57) ALDH1A1MAPTKMT2ASMN1; SMN2RAB9A
SCHEMBL8856704 0.67 SENP6 (0.57) ALDH1A1MAPTKMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5648381-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1997-07-15 US disclosed
EP-0566446-B1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed